Literature DB >> 7547027

Single catheter approach for occlusion of a patent arterial duct with a Rashkind double umbrella.

S E Abrams1, K P Walsh, E A McDonald, A E Boothroyd.   

Abstract

OBJECTIVES: To determine the benefits of using a single venous catheter and a single angiogram during catheter occlusion of a patient arterial duct with the Rashkind double umbrella compared with those of venous and arterial catheters and multiple angiograms.
DESIGN: Retrospective review of case notes. PATIENTS: 103 consecutive patients. The long sheath could not be advanced adequately in two patients. 101 patients had 104 implantations. Median (range) age was 35 (7-549) months and median (range) weight 13 (7-62) kg. Fifty four implantations were performed using the venous and arterial method and 50 using the venous only method.
RESULTS: Median procedure times (70 v 90 min), number of angiograms (one v four), and angiographic dye volume used (2 v 7 ml/kg) were significantly reduced using the venous only method compared with those of the venous and arterial method. There was no significant difference in fluoroscopy time (venous only 9 v venous and arterial 10 min).
CONCLUSIONS: Considerable improvements can be made in the technique of catheter closure of patent arterial ducts using the Rashkind double umbrella without compromising outcome using venous cannulation alone and a single angiogram, rather than venous and arterial cannulation and multiple angiograms. reduced risk to arteries from cannulation, The benefits are reduced radiation exposure, reduced risk to arteries from cannulation, shorter procedures, and lower equipment costs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7547027      PMCID: PMC484023          DOI: 10.1136/hrt.74.3.300

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  14 in total

1.  Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlusion.

Authors:  A Krichenko; L N Benson; P Burrows; C A Möes; P McLaughlin; R M Freedom
Journal:  Am J Cardiol       Date:  1989-04-01       Impact factor: 2.778

2.  A review of children after arterial catheterisation of the leg.

Authors:  B Jacobsson; L E Carlgren; G Hedvall; R Sivertsson
Journal:  Pediatr Radiol       Date:  1973-07

3.  Energy imparted to neonates during X-ray examinations in a special care baby unit.

Authors:  C L Chapple; K Faulkner; E W Hunter
Journal:  Br J Radiol       Date:  1994-04       Impact factor: 3.039

4.  Pulmonary edema in infants following injection of contrast media for urography.

Authors:  B P Wood; W L Smith
Journal:  Radiology       Date:  1981-05       Impact factor: 11.105

5.  Angiographic determination of arterial patency after percutaneous catheterization in infants and small children.

Authors:  R A Hurwitz; E A Franken; D A Girod; J A Smith; W L Smith
Journal:  Circulation       Date:  1977-07       Impact factor: 29.690

6.  Iliofemoral arterial complications of balloon angioplasty for systemic obstructions in infants and children.

Authors:  P E Burrows; L N Benson; W G Williams; G A Trusler; J Coles; J F Smallhorn; R M Freedom
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

7.  Transcatheter occlusion of the persistently patent ductus arteriosus. Forty-month follow-up and prevalence of residual shunting.

Authors:  M C Hosking; L N Benson; N Musewe; J D Dyck; R M Freedom
Journal:  Circulation       Date:  1991-12       Impact factor: 29.690

8.  Catheter occlusion of the persistently patent ductus arteriosus.

Authors:  J D Dyck; L N Benson; J F Smallhorn; P R McLaughlin; R M Freedom; R D Rowe
Journal:  Am J Cardiol       Date:  1988-11-15       Impact factor: 2.778

9.  Nonsurgical closure of patent ductus arteriosus: clinical application of the Rashkind PDA Occluder System.

Authors:  W J Rashkind; C E Mullins; W E Hellenbrand; M A Tait
Journal:  Circulation       Date:  1987-03       Impact factor: 29.690

10.  Radiation dosimetry.

Authors:  J Cameron
Journal:  Environ Health Perspect       Date:  1991-02       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.